Institute Of Oncology Ljubljana
Clinical trials sponsored by Institute Of Oncology Ljubljana, explained in plain language.
-
New combo attack on tough pancreatic cancer
Disease control Recruiting nowThis study is testing whether a two-step treatment can better control pancreatic cancer that cannot be removed by surgery. Adults with locally advanced disease will first receive standard chemotherapy. If the cancer does not worsen, they will then receive a highly focused, high-d…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Doctors test pinpoint radiation to control spine cancer spread
Disease control Recruiting nowThis study aims to monitor the safety and effectiveness of a precise radiation technique called SBRT for treating cancer that has spread to the spine. It will follow 100 adult patients with spinal metastases to track side effects and how well the treatment controls tumor growth. …
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Slovenian study seeks key to predicting skin cancer treatment success
Disease control Recruiting nowThis study is looking at how well immunotherapy drugs work for people in Slovenia with advanced melanoma that has spread. It will follow 100 adults receiving these drugs as their first treatment. Researchers also want to see if measuring a specific protein (PD-L1) in the tumor or…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Slovenian study seeks clues in blood and stool to predict melanoma treatment success
Disease control Recruiting nowThis study is testing how well immunotherapy works as a first treatment for people in Slovenia with advanced melanoma that has spread. It will follow 40 patients to see how their cancer responds and how long it stays under control. Researchers will also collect blood, stool, and …
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Surgery drug showdown: which one boosts cancer Patients' immune systems?
Disease control Recruiting nowThis study is testing which of two common drugs works better to support the body's defenses and recovery after colon cancer surgery. One hundred patients will be randomly assigned to receive either an infusion of lidocaine or a high dose of dexamethasone during their operation. R…
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Electric pulses and drug combo may spare women from mutilating vulvar cancer surgery
Disease control Recruiting nowThis study is testing a treatment called electrochemotherapy for women whose vulvar cancer has come back. The treatment combines a cancer drug with electric pulses to help the drug get into the tumor cells more effectively. The main goal is to shrink the tumors enough to avoid or…
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Common numbing drug may help colon cancer patients heal faster
Disease control Recruiting nowThis study is testing if giving the numbing medicine lidocaine during and after colon cancer surgery helps patients recover better. Researchers will compare it to a placebo and a steroid to see if it reduces pain, lowers the need for strong painkillers (opioids), and helps the bo…
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Traffic-Light app aims to catch cancer treatment side effects faster
Symptom relief Recruiting nowThis study is testing a new web application designed to help cancer patients report side effects from radiation therapy. Patients with breast, gynecologic, or urologic cancers will use the app weekly to log symptoms, which are sent securely to their doctors. The system uses a red…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Scientists probe why breast cancer patients skip their meds
Knowledge-focused Recruiting nowThis study aims to understand how consistently patients take their breast cancer medications. Researchers will compare two groups: those taking a standard hormone therapy pill versus those taking that pill plus an additional drug called abemaciclib. They will track 319 patients f…
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Apr 01, 2026 19:56 UTC
-
Simple questionnaire aims to spot hidden muscle loss in cancer patients
Knowledge-focused Recruiting nowThis study is testing a short questionnaire to identify gastrointestinal cancer patients at risk for sarcopenia—a serious loss of muscle mass and strength. Researchers want to see how many patients screen positive for this risk before starting cancer treatment and again during tr…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Tracking cancer cells in blood to predict survival
Knowledge-focused Recruiting nowThis study aims to see if cancer cells and DNA found in the blood can help predict how well treatment works for aggressive, high-risk early breast cancer. Researchers will enroll 130 patients with inflammatory or triple-negative/HER2+ breast cancer. They will use blood tests to t…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Scientists track 'Chemo Brain' in lymphoma patients
Knowledge-focused Recruiting nowThis study aims to understand how often lymphoma patients experience memory and thinking problems during and after chemotherapy. Researchers will track patients' cognitive function over time using standard tests and analyze spinal fluid in some patients to look for biological mar…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC
-
Tracking the hidden costs of cancer survival
Knowledge-focused Recruiting nowThis study aims to understand how colorectal cancer survivors feel and function in the years after their treatment ends. Researchers will follow 368 working-age survivors for up to 2 years, checking in at 6, 12, and 24 months. The goal is to identify common long-term side effects…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC
-
Scientists probe how to feed patients who Can't eat
Knowledge-focused Recruiting nowThis study aims to better understand how much protein patients with severe intestinal failure need when they rely on intravenous nutrition at home. Researchers will measure how 40 patients' bodies process protein to help create more personalized nutrition formulas. The goal is to…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC
-
Scientists probe how electric shocks and chemo reshape the tumor battlefield
Knowledge-focused Recruiting nowThis study aims to understand how a local treatment called electrochemotherapy changes the environment inside and around melanoma skin tumors. Researchers will treat patients who have melanoma that has spread to the skin and take small tissue samples before and after treatment. B…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:27 UTC
-
Hidden muscle loss in cancer patients: new study seeks answers
Knowledge-focused Recruiting nowThis study aims to find out how many people with stomach or intestinal cancers show early warning signs of muscle loss, known as sarcopenia. Researchers will screen 60 patients using a simple questionnaire before they start cancer treatment and again during treatment. Patients wh…
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC